Opinion | March 24, 2022
Clinical Trials in the New Normal
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
This announcement comes after the formation of a new Intercontinental Region within GE Healthcare, led by Chaillot
The expansion makes Exothera one of the largest viral vector facilities in Europe
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
According to IQVIA sales data for the period ending January 2022, Vimpat tablets market achieved annual sales of approx. US $ 1.7 billion
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
Subscribe To Our Newsletter & Stay Updated
